Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Biotools
  • Published:

Atherosclerosis Patents: Clues to the Next Drug Generation

Bio/Technology volume 12, pages 1379–1380 (1994)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Steinberg, D. 1989. The cholesterol controversy is over. Why did it take so long? Circulation 80: 1070–1078.

    Article  CAS  Google Scholar 

  2. Fuessner, G. 1994. HMG-CoA reductase inhibitors. Current Opinion in Lipidology 5: 59–68.

    Article  Google Scholar 

  3. Brown, B.G., Zhao, X.-Q., Sacco, D.E. and Albers, J.J. 1993. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 87: 1781–1791.

    Article  CAS  Google Scholar 

  4. Bergstrom, J.D., et al. 1993. Zaragozic acids, a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci. USA 90: 80–84.

    Article  CAS  Google Scholar 

  5. Baxter, A., et al. 1992. Squalestatin 1, a potent inhibitor of squalene synthase which lowers serum cholesterol in vivo. J. Biol. Chem. 267: 11705–11708.

    CAS  PubMed  Google Scholar 

  6. Picard, J.A. 1993. ACAT inhibitors. Current Opinion in Therapeutic Patents 3: 151–160.

    Article  Google Scholar 

  7. Suckling, K.E. 1993. Emerging strategies for the treatment of atherosclerosis as seen from the patent literature. Biochem. Soc. Trans. 21: 660–662.

    Article  CAS  Google Scholar 

  8. Ross, R. 1993. Pathology of atherosclerosis: A perspective for the 1990s. Nature 362: 801–809.

    Article  CAS  Google Scholar 

  9. Fears, R., Suckling, K.E. and Poste, G. 1994. Novel agents in the treatment of atherosclerosis. Expert Opinion in Investigationat Drugs 3: 481–491.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. director of the cellular pharmacology and biochemistry unit, department of vascular biology, SmithKline Beecham Pharmaceuticals Research and Development, The Frythe, Welwyn, Hertfortshire, AL6 9AR, U.K.

    Keith E. Suckling

Authors
  1. Keith E. Suckling
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suckling, K. Atherosclerosis Patents: Clues to the Next Drug Generation. Nat Biotechnol 12, 1379–1380 (1994). https://doi.org/10.1038/nbt1294-1379

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1294-1379

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing